In " Beyond Diagnosis: CLL," Cleveland Clinic hematologist/oncologist Allison Winter, MD, and host John Mangels explore how ...
For patients who have chronic lymphocytic leukemia (CLL), experiencing Richter transformation with central nervous system ...
In the first Untitled Letter issued by the FDA in 2026, BeOne Medicines was critiqued for a DTC TV ad promoting its BTK ...
The FDA's approval of zanubrutinib tablets reduces pill burden, potentially improving adherence, especially in older CLL patients, and solidifies its market leadership among Bruton tyrosine kinase ...
Some cancers may not require immediate treatment, from prostate cancer to thyroid tumors. Medical experts share when ...
Nurix Therapeutics (NRIX) stock: bexobrutideg’s BTK degradation shows strong efficacy in B-cell cancers, backed by $650M cash ...
San Carlos, California Thursday, January 8, 2026, 13:00 Hrs [IST] ...
Fay said "the hardest chapter" of his life inspired him to create a nonprofit that initiates and inspires kind acts.
The narrative highlights the importance of creating intentional spaces of silence and mindfulness amidst the chaos of chronic illness. Drawing parallels between ikebana and living with leukemia, it ...
Preliminary but promising.Those three words emerged as a recurring theme in conversations about several abstracts presented at this year’s ASH Annual Meeting and Exposition that examined the effects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback